HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat

Date Issued
2016
Author(s)
Angelika Ihle, Michaela
Merkelbach‐Bruse, Sabine
Hartmann, Wolfgang
Ratner, Nancy
Sonobe, Hiroshi
Nishio, Jun
Larsson, Olle
Åman, Pierre
Pedeutour, Florence
Taguchi, Takahiro
Wardelmann, Eva
Buettner, Reinhard
DOI
10.1002/cjp2.v2.2